BDMD vs. TELA, APYX, GUTS, NVNO, MDAI, NSPR, SRTS, ZYXI, CTSO, and HYPR
Should you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include TELA Bio (TELA), Apyx Medical (APYX), Fractyl Health (GUTS), enVVeno Medical (NVNO), Spectral AI (MDAI), InspireMD (NSPR), Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.
Baird Medical Investment vs. Its Competitors
Baird Medical Investment (NASDAQ:BDMD) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.
Baird Medical Investment has a beta of -0.94, indicating that its share price is 194% less volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.
In the previous week, Baird Medical Investment and Baird Medical Investment both had 5 articles in the media. TELA Bio's average media sentiment score of 0.69 beat Baird Medical Investment's score of 0.37 indicating that TELA Bio is being referred to more favorably in the news media.
Baird Medical Investment has a net margin of 0.00% compared to TELA Bio's net margin of -61.00%. Baird Medical Investment's return on equity of 0.00% beat TELA Bio's return on equity.
19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Comparatively, 4.7% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
TELA Bio has a consensus price target of $7.25, suggesting a potential upside of 277.60%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts clearly believe TELA Bio is more favorable than Baird Medical Investment.
Baird Medical Investment has higher earnings, but lower revenue than TELA Bio.
Summary
TELA Bio beats Baird Medical Investment on 7 of the 11 factors compared between the two stocks.
Get Baird Medical Investment News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Baird Medical Investment Competitors List
Related Companies and Tools
This page (NASDAQ:BDMD) was last updated on 7/25/2025 by MarketBeat.com Staff
